Successful implementation of the Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women, developed with Persei vivarium technology
by Paola Bello and Patricia Domínguez, October 14, 2020
In mid-March of 2020, the Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women was implemented by its principal investigator, Dr. Óscar Martínez, who practices in the Obstetrics and Gynecology department at the Puerta de Hierro University Hospital. The registry is managed with technology from our company, Persei vivarium.
The project was prompted by the COVID-19 pandemic, when it became obvious that a tool was needed to share and centralize data about exposure to SARS-CoV-2 during pregnancy in order to develop protocols for managing the disease in this specific group of patients. Another goal of the initiative was to determine the incidence rate in asymptomatic pregnant coronavirus carriers.
Since its launch, the registry has been progressing successfully. It has 100 participating Spanish centers, and is enabling the observation of significant results like a trend of decreased incidence of SARS CoV-2 infection in asymptomatic patients, going from an average positive rate in Spain of 6.5% at the beginning of April 2020 to an average of 0.93% at the end of May 2020. This was reported in the article “Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women”, published in the Spanish Review of Public Health, issued by the Spanish Ministry of Health.
Our company’s technology was used for the development and implementation of this project, which created a common framework for the collection of data in the different centers, facilitating the organization and structuring of the collected data, and thus helping in joint decision-making.
Today, after six months of operation, the Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women is enabling us to access detailed, high-quality, national-level information about how COVID-19 is affecting this specific population group. For our part, we are certain that this project will continue providing high-value data in this current situation, creating a greater understanding of this significant disease.